Oregon Public Employees Retirement Fund’s Corcept Therapeutics CORT Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.88M	Buy	21,676 +300	+1%	+$18.1K	0.02%	599
2026 Q1	$862K	Buy	21,376 +4	+0%	+$150	0.01%	925
2025 Q4	$744K	Buy	21,372 +293	+1%	+$23K	0.01%	997
2025 Q3	$1.75M	Sell	21,079 -361	-2%	-$26.1K	0.02%	564
2025 Q2	$1.57M	Buy	21,440 +270	+1%	+$19.6K	0.03%	541
2025 Q1	$2.42M	Sell	21,170 -800	-4%	-$48.7K	0.05%	331
2024 Q4	$1.11M	Buy	21,970 +54	+0.2%	+$2.83K	0.02%	747
2024 Q3	$1.01M	Sell	21,916 -307	-1%	-$10.9K	0.02%	802
2024 Q2	$722K	Sell	22,223 -2,100	-9%	-$57.5K	0.01%	927
2024 Q1	$613K	Sell	24,323 -2,100	-8%	-$49.6K	0.01%	1082
2023 Q4	$858K	Sell	26,423 -412	-2%	-$11.3K	0.02%	970
2023 Q3	$731K	Sell	26,835 -1,300	-5%	-$37.6K	0.01%	1123
2023 Q2	$626K	Sell	28,135 -2,627	-9%	-$60.5K	0.01%	1217
2023 Q1	$666K	Sell	30,762 -1,080	-3%	-$23.7K	0.01%	1191
2022 Q4	$647K	Buy	31,842 +300	+1%	+$7.52K	0.01%	1193
2022 Q3	$809K	Buy	31,542 +178	+0.6%	+$4.76K	0.01%	1041
2022 Q2	$746K	Sell	31,364 -4,586	-13%	-$99.9K	0.01%	960
2022 Q1	$810K	Sell	35,950 -3,062	-8%	-$65.1K	0.01%	1179
2021 Q4	$772K	Sell	39,012 -3,679	-9%	-$74.6K	0.01%	1129
2021 Q3	$840K	Sell	42,691 -200	-0.5%	-$4.19K	0.01%	1087
2021 Q2	$944K	Hold	42,891	–	–	0.01%	1060
2021 Q1	$1.02M	Buy	42,891 +1,299	+3%	+$34.7K	0.01%	1006
2020 Q4	$1.09M	Sell	41,592 -654	-2%	-$13.8K	0.01%	866
2020 Q3	$735K	Buy	42,246 +1,150	+3%	+$18.3K	0.01%	933
2020 Q2	$691K	Hold	41,096	–	–	0.01%	963
2020 Q1	$489K	Hold	41,096	–	–	0.01%	1032
2019 Q4	$497K	Sell	41,096 -1,000	-2%	-$13.9K	0.01%	1216
2019 Q3	$595K	Buy	42,096 +700	+2%	+$8.6K	0.01%	1191
2019 Q2	$462K	Buy	41,396 +700	+2%	+$7.8K	0.01%	1297
2019 Q1	$478K	Buy	40,696 +735	+2%	+$9.13K	0.01%	1272
2018 Q4	$534K	Buy	+39,961	New	+$528K	0.01%	1189

Other funds holding CORT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oregon Public Employees Retirement Fund's CORT Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Corcept Therapeutics (CORT) stake by 1.4% in Q2 2026, buying an estimated $18.1K and bringing the position to 21,676 shares worth $1.88M. The position accounts for 0.02% of the portfolio, ranked #599.

Oregon Public Employees Retirement Fund first reported a position in CORT in Q4 2018 and has held it in 31 quarters since. The position peaked at $2.42M in Q1 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

Oregon Public Employees Retirement Fund held 21,676 shares of Corcept Therapeutics worth $1.88M as of Q2 2026.
Oregon Public Employees Retirement Fund bought 300 Corcept Therapeutics shares in Q2 2026, an estimated $18.1K.
Corcept Therapeutics made up 0.02% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #599 holding.
Oregon Public Employees Retirement Fund first reported a position in Corcept Therapeutics in Q4 2018 and has held it in 31 quarters since.
Oregon Public Employees Retirement Fund's Corcept Therapeutics position peaked at $2.42M in Q1 2025.
423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.